HIG
75
4
RF
50
2
UA
33
-2
MMC
54
6
VLO
39
11
TSCO
52
-3
MTCH
42
-11
MSFT
62
4
NOV
58
5
SPG
56
3
CAG
48
-2
JNJ
32
2
KIM
48
-2
NI
60
2
L
58
3
GME
79
-9
OI
41
4
NVDA
65
4
CNX
69
6
BXP
54
5
HIG
75
4
RF
50
2
UA
33
-2
MMC
54
6
VLO
39
11
TSCO
52
-3
MTCH
42
-11
MSFT
62
4
NOV
58
5
SPG
56
3
CAG
48
-2
JNJ
32
2
KIM
48
-2
NI
60
2
L
58
3
GME
79
-9
OI
41
4
NVDA
65
4
CNX
69
6
BXP
54
5
Financhill
Back

Ocular Therapeutix 10K Form

Buy
54

OCUL
Ocular Therapeutix

Last Price:
5.93
Seasonality Move:
-4.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUL News And Ratings

See the #1 stock for the next 7 days that we like better than OCUL

OCUL Financial Statistics

Sales & Book Value

Annual Sales: $58.44M
Cash Flow: $-22.91M
Price / Cash Flow: 0
Annual Sales: $0.79
Price / Book: 9.48

Profitability

EPS (TTM): -1.25000
Net Income (TTM): $-80.74M
Gross Margin: $53.16M
Return on Equity: -274.31%
Return on Assets: -49.54%

Ocular Therapeutix Earnings Forecast

Key Ocular Therapeutix Financial Ratios

  • The Gross Profit Margin over the past 12 years for OCUL is 90.96%.
  • The Selling, General & Administrative Expenses for OCUL have been equal to 127.46% of Gross Profit Margin.
  • The Research & Development expenses have been 104.47% of Revenue.
  • The Interest Expense is -14.04% of Operating Income.
  • The Net Earning history of OCUL is -138.14% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Ocular Therapeutix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUL
CUSIP: 67576A
Website: ocutx.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 6.66
Quick Ratio: 6.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OCUL Technical Analysis vs Fundamental Analysis

Buy
54
Ocular Therapeutix (OCUL) is a Buy

Is Ocular Therapeutix a Buy or a Sell?